It’s also available as the brand-name injection Saxenda, which is approved for weight loss. Victoza has a boxed warning. A boxed warning is the most serious warning from the Food and Drug ...

Insurance coverage for GLP-1 drugs remains tight despite rising demand, with more patients facing restrictions or paying out ...

The study used the company's older GLP-1 agonist therapy Saxenda (liraglutide), which requires a daily injection, rather than its top-selling once-weekly obesity drug Wegovy (semaglutide), and ...

Saxenda continues to develop a dominant position in obesity pharmacotherapy however, and Novo Nordisk said the drug currently has a market share of 63% worldwide.

This opens the door to the possibility of Lexaria developing and selling the world's first oral capsule or tablet version of ... the DehydraTECH-processing of Saxenda® to the conventional ...